October Pharma will distribute EGP 3 per share on June 13th, according to the company’s statement filed to the Egyptian Exchange.
The company stated the dividends will be disbursed to the shareholders recorded on June 8th.
October Pharma reported a net profit of EGP 88.26 in 2020, a 161% rise from EGP 33.8 million achieved in 2019.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.
Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
